![Jörn SCHATTENBERG | Director Metabolic Liver Research Program | Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz | Research profile Jörn SCHATTENBERG | Director Metabolic Liver Research Program | Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz | Research profile](https://i1.rgstatic.net/ii/profile.image/272164662280218-1441900520351_Q512/Joern-Schattenberg.jpg)
Jörn SCHATTENBERG | Director Metabolic Liver Research Program | Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz | Research profile
![A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B - ScienceDirect A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827822034705-gr1.jpg)
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B - ScienceDirect
![Hepatologische Forschungsvernetzung durch zwei Stipendien der Deutschen Leberstiftung gefördert | GESUNDHEIT ADHOC Hepatologische Forschungsvernetzung durch zwei Stipendien der Deutschen Leberstiftung gefördert | GESUNDHEIT ADHOC](https://www.gesundheit-adhoc.de/files/1688381794_21e11173.jpg)
Hepatologische Forschungsvernetzung durch zwei Stipendien der Deutschen Leberstiftung gefördert | GESUNDHEIT ADHOC
![Frontiers | Hepatoprotectant Ursodeoxycholyl Lysophosphatidylethanolamide Increasing Phosphatidylcholine Levels as a Potential Therapy of Acute Liver Injury Frontiers | Hepatoprotectant Ursodeoxycholyl Lysophosphatidylethanolamide Increasing Phosphatidylcholine Levels as a Potential Therapy of Acute Liver Injury](https://www.frontiersin.org/files/Articles/21750/fphys-03-00024-HTML/image_m/fphys-03-00024-g001.jpg)
Frontiers | Hepatoprotectant Ursodeoxycholyl Lysophosphatidylethanolamide Increasing Phosphatidylcholine Levels as a Potential Therapy of Acute Liver Injury
![PDF) Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease | Wolfgang Stremmel and Gerhard Liebisch - Academia.edu PDF) Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease | Wolfgang Stremmel and Gerhard Liebisch - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/41202161/mini_magick20190219-949-1lns7zt.png?1550631427)
PDF) Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease | Wolfgang Stremmel and Gerhard Liebisch - Academia.edu
Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury | PLOS ONE
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
![A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B - ScienceDirect A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827822034705-gr3.jpg)
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B - ScienceDirect
![Dr. Anita Pathil-Warth, Assistenzärztin an der Abteilung für Gastroenterologie an der Medizinischen Universitätsklinik Heidelberg. - abitur-und-studium.de Dr. Anita Pathil-Warth, Assistenzärztin an der Abteilung für Gastroenterologie an der Medizinischen Universitätsklinik Heidelberg. - abitur-und-studium.de](https://www.abitur-und-studium.de/Bilder/Dr-Anita-Pathil-Warth-Assistenzaerztin-an-der-Abteilung-fuer-Gastroenterologie-an-der-Medizinischen-Universitaetsklinik-Heidelberg.jpg)
Dr. Anita Pathil-Warth, Assistenzärztin an der Abteilung für Gastroenterologie an der Medizinischen Universitätsklinik Heidelberg. - abitur-und-studium.de
![HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis | BMC Cancer | Full Text HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6320-y/MediaObjects/12885_2019_6320_Fig2_HTML.png)